Prospective Study of 2 mm Margins for the Biopsy of Dysplastic Nevi
Learn more about:
Related Clinical Trial
BioMEL- Diagnostic and Prognostic Factors in Melanoma.
Atypical MOLes and Melanoma Early Detection Study (MoleMed)
Artificial Intelligence-assisted Evaluation of Pigmented Skin Lesions
Prospective Study of 2 mm Margins for the Biopsy of Dysplastic Nevi
Evaluation of 20% Betulinic Acid Ointment for Treatment of Dysplastic Nevi (Moderate to Severe Dysplasia)
Internet-based Intervention for Skin Self-Examination in Participants With Increased Risk for Melanoma